BioSpace News Archive

Pharm Country

American Regent Launches a New Vial Presentation

American Regent, Inc. and Provepharm Life Solutions are pleased to announce the availability of ProvayBlue® Injection, USP in a 10 mL single-dose vial.

June 30, 2022
·
11 min read
ERC Announces Publication of Positive Efficacy Data with Sitoiganap in Patients with Recurrent Glioblastoma

ERC Belgium S.A., announced publication of its most recent efficacy data in the May 2022 edition of Frontiers in Oncology.

June 30, 2022
·
3 min read
Drug Development

Ultimovacs Completes Patient Recruitment in INITIUM Phase II Trial of UV1 in Malignant Melanoma

Ultimovacs ASA, a clinical stage leader in immune stimulatory vaccines for cancer, announces the completed recruitment of 154 patients in the INITIUM trial.

June 30, 2022
·
4 min read
Fiducial Markers Market is Projected to Experience Promising Growth Opportunities in the Forthcoming Years

Fiducial markers, also known as fiducial, can be defined as the object placed in the viewing field of an imaging system, which appears in the image produced, and which can be used as a point of measure or reference.

June 30, 2022
·
4 min read
Global Cancer Diagnostics Market Witnessing a Remarkable Surge in its Size, Forecast, 2031

With the tremendous rise in the prevalence of cancer across the world, the global market for cancer diagnostics is witnessing a remarkable surge in its size.

June 30, 2022
·
8 min read
Secure Messaging in Healthcare Market Predicted to Witness Surge in The Near Future

Wilmington, Delaware, United States: The global secure messaging in healthcare market is estimated to show upward curve of revenues during the forecast period of 2019 to 2028.

June 30, 2022
·
5 min read
Metabolomics Market 2031, Current Trends | Regional Outlook | Competitive Analysis

Metabolomics is the examination of small molecules, commonly known as metabolites. Such molecules are typically found inside cells, tissues, biofluids, or organisms.

June 30, 2022
·
8 min read
Number of shares and votes in Calliditas Therapeutics - June 30, 2022

During June, Calliditas Therapeutics AB has issued 5,908,018 class C-shares as part of the establishment of the company’s at-the-market program.

June 30, 2022
·
1 min read
HIV Diagnosis Market Growth Rate and Current Trends | Industry Outlook, 2031

Human immunodeficiency virus is the virus responsible for incidence of the disease acquired immunodeficiency syndrome which is caused by the constant decline in T-helper cells in the body.

June 30, 2022
·
8 min read
Genetown

BeiGene Announces Late-Breaking Data at ESMO GI Showing Overall Survival Benefit for Tislelizumab Plus Chemotherapy in First-Line Advanced or Metastatic Esophageal Squamous Cell Carcinoma

BeiGene announced new data from RATIONALE 306, a global Phase 3 trial evaluating tislelizumab plus chemotherapy in adult patients with advanced or metastatic esophageal squamous cell carcinoma without prior systemic treatment for advanced disease.

June 30, 2022
·
9 min read